Session Details

Asia Symposium on Pharmaceutical Sciences for the Next Generation: Clinical Research 2

Sun. Mar 31, 2024 3:30 PM - 5:30 PM JST
Sun. Mar 31, 2024 6:30 AM - 8:30 AM UTC
[Room 418] Conference Center 418 (4F)
Organizer: Yoshiharu Iwabuchi (Grad. Sch. Pharm. Sci., Tohoku Univ.), Yoshio Hayashi (Tokyo Univ. of Pharm. and Life Sci.), Yoshinobu Takakura (Kyoto Univ.), Itsuko Ishii (Div. Pharm., Chiba Univ. Hosp.)
Chair: Itsuko Ishii (Div. Pharm., Chiba Univ. Hosp.), Hisakazu Ohtani (Keio Univ. Sch. Med./Fac. Pharm.)
This symposium will focus on new systems and data sciences in the clinical field. Dr. Kelly Grindrod from Canada, Dr. Alex C. Lin from the United States, Dr. Hsiang-Wen (Margaret) Lin and Dr. Yu-Chieh (Jack) Chen from Taiwan, and Dr. Rho Inose and Dr. Yuta Tamemoto from Japan will give lectures. System development and data science will open new doors in the field of medical pharmacy. Let's discuss together.

[IS04-1]Smart design: Exploring the role of interdisciplinary collaborations in technology research and design for healthcare

○Kelly A. Grindrod1 (1. School of Pharmacy, University of Waterloo)

[IS04-2]The Pharmacy 5.0 Framework: A New Paradigm to Accelerate Innovation for Large-Scale Personalized Pharmacy Care and Its Applications

○Alex C. Lin1, Jay Lee2, Mina Gabriel1, Andrew M. Ferguson1, Yazeed Ghawaa1 (1. Division of Pharmacy Practice and Administrative Sciences, The James L. Winkle College of Pharmacy, University of Cincinnati, Cincinnati, Ohio, USA, 2. A. James Clark School of Engineering, Maryland Robotics Center, University of Maryland, Baltimore, Maryland, USA; College of Engineering and Applied Science, University of Cincinnati, Cincinnati, Ohio, USA)

[IS04-3]Prediction Models through Machine Learning Approaches to Facilitate Optimal Medication Use in Taiwan

○Hsiang-Wen Lin1,2,3, Chen-Yuan Lin1,4, Daniel Hsiang-Te Tsai1,5, Bo-Yi Chen1, Tien-Chao Lin2, Guan-Lin Shen2, Meng-Yu Lin2, Chun-Wei Tu2 (1. School of Pharmacy and Graduate Institute, College of Pharmacy, China Medical University (CMU), Taiwan, 2. Department of Pharmacy, China Medical University Hospital (CMUH), Taiwan, 3. Department of Pharmacy System, Outcomes and Policy, College of Pharmacy, University of Illinois at Chicago, United States, 4. Division of Hematology and Oncology, China Medical University Hospital, Taiwan, 5. School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan)

[IS04-4]Exploring Robotic Chemotherapy Compounding: A Technology Acceptance Model (TAM)-based Perspective among Compounding Pharmacists and Pharmacy Managers in Taiwan

○Yu-Chieh (Jack) Chen1 (1. School of Pharmacy, China Medical University / Department of Pharmacy, China Medical University Hospital)

[IS04-5]Evaluation for drug safety based on real-world data

○Ryo Inose1 (1. Laboratory of Clinical Pharmacoepidemiology, Kyoto Pharmaceutical University)

[IS04-6]Clinical science for drug post-marketing of small molecule drugs and antibody therapeutics based on medical big data analysis

○Yuta Tamemoto1 (1. Grad. Sch. Pharm. Sci., Chiba Univ.)

Closing: Hisakazu Ohtani (Keio Univ. Sch. Med./Fac. Pharm., Keio Univ. Hosp., Dept. Pharm.)